Showing 341 - 360 results of 2,756 for search 'materials dysfunction', query time: 0.11s Refine Results
  1. 341

    TRIMETAZIDINE MB ROLE IN THE OPTIMISATION OF THE ACUTE CORONARY SYNDROME TREATMENT: EFFECTS ON ENDOTHELIAL DYSFUNCTION AND SYSTEMIC INFLAMMATION by S. I. Davydov, V. V. Titova, M. A. Gordeeva, A. A. Tarasov, A. R. Babaeva

    Published 2013-12-01
    “…To study the effects of trimetazidine MB therapy on the clinical manifestations and markers of endothelial dysfunction and systemic inflammation in patients with acute coronary syndrome (ACS). …”
    Get full text
    Article
  2. 342

    Clinical role of endothelial dysfunction and hemostasis gene allelic variants in hepatitis C virus-associated cryoglobulinemia by M. V. Sokolova, Ye. Ye. Starostina, T. N. Krasnova, L. M. Samokhodskaya, T. P. Rozina, V. G. Avdeyev, M. G. Artemova, Ye. B. Yarovaya, N. A. Mukhin

    Published 2018-08-01
    “…Material and methods. Original study included overall 72 patients with CHC and cryoglobulinemia: 21 patients had CryoVas, 51 - CHC without vasculitis. …”
    Get full text
    Article
  3. 343

    CARDIOPROTECTIVE EFFECT OF PHYSICAL REHABILITATION IN PATIENTS WITH ISCHEMIC-ORIGIN DIASTOLIC DYSFUNCTION AFTER PERCUTANEOUS CORONARY INTERVENTION by N. P. Lyamina, A. N. Nosenko, I. B. Razborova, O. V. Orlikova, E. V. Kotel'nikova, E. S. Karpova

    Published 2015-12-01
    “…Material and methods. Patients with ICD (n=60, all males, aged from 49 to 58 years) who had undergone PCI last 3–6 weeks were included into the study. …”
    Get full text
    Article
  4. 344

    Choice of an Infusion Agent for the Prevention of Multiple Organ Dysfunction in Acute Massive Blood Loss (Experimental Study) by A. Yu. Yakovlev, N. V Yemelyanov, I. V. Mukhina, A. V., Dvornikov, L. B. Snopova, G. V. Kalentyev, D. V. Ryabikov, N. V. Mineyeva

    Published 2010-06-01
    “…Key words: acute massive blood loss, malate, sterofun dinisotonic, lactate, endotoxemia, multiple organ dysfunction.…”
    Get full text
    Article
  5. 345

    EFFECT OF ARTERIAL HYPERTENSION ON LEFT VENTRICULAR GEOMETRIC REMODELING AND LEFT ATRIAL MECHANICAL DYSFUNCTION IN ATRIAL FIBRILLATION by M. Ya. Dotsenko, S. S. Boev, O. V. Molodan, L. V. Gerasimenko, I. O. Shehunova, O. Ya. Malinovska

    Published 2022-06-01
    “…Purpose: to study changes in the structural and functional parameters of the left atrium and left ventricle in patients with arterial hypertension and atrial fibrillation. Material and methods. The study involved 52 patients with stage II-III arterial hypertension, which were divided into 2 groups depending on the presence or absence of atrial fibrillation. …”
    Get full text
    Article
  6. 346

    Alprazolam therapy effects on quality of life and vegetative dysfunction syndrome in patients with idiopathic mitral valve prolapse by E. V. Akatova, E. D. Sukhanova, O. P. Nikolin, A. I. Martynov

    Published 2010-02-01
    “…Material and methods. This single-blind, placebo-controlled study included 60 patients with idiopathic MVP (33,3% men, 66,7% women). …”
    Get full text
    Article
  7. 347

    RELATION OF THE MARKERS OF MYOCARDIAL DYSFUNCTION AND SYSTEMIC INFLAMMATION WITH STRUCTURAL AND FUNCTIONAL PARAMETERS OF THE LUNGS IN MYOCARDIAL INFARCTION PATIENTS by O. M. Polikutina, Y. S. Slepynina, E. D. Bazdyrev, V. N. Karetnikova, O. L. Barbarach

    Published 2018-04-01
    “…To evaluate the structural and functional changes in the lungs of ST elevation myocardial infarction (STEMI) patients with absence or presence of chronic obstructive lung disease (COPD), and the relation with myocardial dysfunction and systemic inflammation.Material and methods. …”
    Get full text
    Article
  8. 348

    Adrenal Dysfunction Caused by Critical Illness and Its Correction by Controlling Body Temperature: Prospective Cohort Study by N. E. Altshuler, N. M. Kruglyakov, M. B. Kutsyi, K. A. Popugaev

    Published 2024-09-01
    “…To improve treatment outcomes for critically ill patients requiring temperature management through early diagnosis and timely correction of adrenal dysfunction.   MATERIAL AND METHODS. Of the 59 patients, 45 (76.3 %) patients were diagnosed with adrenal dysfunction upon body temperature management (BTM) caused by critical illness: group I with vascular failure (VF+); in 14 (23.7 %) patients of group II adrenal disfunction wasn’t revealed (VF-).   …”
    Get full text
    Article
  9. 349

    Features of cardiovascular remodeling, the level of neurohumoral factors depending on the degree of chronic heart failure and kidney dysfunction by U. K. Kamilova, Z. D. Rasulova, G. A. Zakirova, B. B. Toshev

    Published 2019-06-01
    “…To study the relationship between the level of the N-terminal prohormone of brain natriuretic peptide (NTproBNP) and aldosterone in serum, cardiovascular remodeling parameters with the degree of chronic heart failure (CHF) and kidney dysfunction (KD).Material and methods. Fifty two patients with coronary artery disease with CHF of I (19 patients), II (21) and III (12) functional classes (FC) were examined. …”
    Get full text
    Article
  10. 350

    Early Results After Coronary Artery Bypass Grafting in Patients With Severe Ischemic Left Ventricular Dysfunction by M. K. Mazanov, P. V. Chernyavsky, M. A. Sagirov, N. M. Bikbova, N. I. Kharitonova, D. V. Chernyshev, A. V. Timerbayev, S. Y. Kambarov

    Published 2020-10-01
    “…To evaluate the early results of surgical myocardial revascularization in patients with coronary artery disease (CAD) and severe ILVD.Material and methods. The study included 149 patients with coronary artery disease with severe left ventricular dysfunction (ejection fraction (EF) ≤39%), operated from January 2002 to December 2018. different variables were assessed (pre- and postoperative), including LV ejection fraction and end systolic volume index (ESVI).Results. …”
    Get full text
    Article
  11. 351

    Low-intensive Laser Therapy for Management of Cerebral Dysfunction in Patients with Obstructive Jaundice of Non-tumor Origin by A. P. Vlasov, I. A. Chigakova, D. E. Timoshkin, M. A. Spirina, V. S. Kuznetsov, N. S. Sheyranov, A. V. Rubtsov

    Published 2019-04-01
    “…The development of hepatic encephalopathy undoubtedly aggravates the course of the disease, which requires its timely management.AIM OF STuDy: to evaluate the effcacy of the low-intensity laser therapy when managing the cerebral dysfunction in mechanical jaundice of non-tumor origin.MATERIAL AND METHODS A comprehensive study of 60 patients with obstructive jaundice of non-tumor origin was performed. …”
    Get full text
    Article
  12. 352

    Importance of NT-pro BNP in the Prevention of Heart Failure, Left Ventricular Systolic Dysfunction and Cardiovascular Events by Irina CUCIUREANU, Cristian Alexandru ION, Anamaria-Georgiana AVRAM, Mihai Aurelian GHITA, Maria Suzana GUBERNA, Catalina Liliana ANDREI, Crina-Julieta SINESCU

    Published 2021-06-01
    “…In the control group, 60 patients (38.2%) were diagnosed with left ventricular systolic dysfunction, compared to 43 patients (27.4%) in the intervention group. …”
    Get full text
    Article
  13. 353

    Changes of myocardial dysfunction and injury biomarkers over chemotherapy for multiple myeloma: difficulties in laboratory data interpretation by E. V. Fomina, S. A. Kardovskaya, D. A. Budanova, P. A. Markin, S. A. Appolonova, A. S. Lishuta, Yu. N. Belenkov, I. S. Ilgisonis

    Published 2023-11-01
    “…All patients underwent standard laboratory (complete blood count, biochemical tests, serum protein electrophoresis), electrocardiography, echocardiography, as well as the level of specific laboratory markers of myocardial dysfunction (NT-proBNP) and injury (hsTnI) was determined immediately before treatment, after 3 and 6 cycles of chemotherapy.Results. …”
    Get full text
    Article
  14. 354
  15. 355

    ASSOCIATION BETWEEN GUSTATORY AND OLFACTORY DYSFUNCTIONS AND GHRELIN, IL-6, AND IL-10 LEVELS IN COVID-19 PATIENTS by Gönül Şeyda Seydel, İnayet Güntürk, Cevat Yazıcı, Füsun Ferda Erdoğan

    Published 2024-10-01
    “…Materials and Methods: A total of 80 COVID-19 patients were enrolled in the study: 57 patients with gustatory and/or olfactory dysfunctions and 23 patients without gustatory or olfactory dysfunctions. …”
    Get full text
    Article
  16. 356
  17. 357

    EFFECTS OF OBESITY DEGREES AND THE PRESENCE OF METABOLIC SYNDROME ON THE SEXUAL LIFE OF WOMEN AND MEN by Bedia Fulya Çalıkoğlu, Büşra Yıldız, Cemile İdiz, Selda Çelik, Hülya Hacışahinoğulları, Serpil Salman, Ayşe Kubat Üzüm, İlhan Satman

    Published 2024-01-01
    “…The probability of having erectile dysfunction (ED) in men with obesity and MetSend is higher than in those without (p>0.05). …”
    Get full text
    Article
  18. 358
  19. 359
  20. 360